A retrospective analysis of relapse-related factors for ovarian borderline tumors

被引:0
作者
Ye, Dan [1 ]
Shen, Haoran [1 ]
Huang, Wu [1 ]
Yao, Liangqing [1 ]
机构
[1] Fudan Univ, Gynecol Dept, Obstet & Gynecol Hosp, 419 Fangxie Rd, Shanghai 200090, Peoples R China
来源
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH | 2022年 / 14卷 / 08期
关键词
Borderline ovarian tumors; fertility-preservation surgery; recurrent-free survival; stage; RECURRENCE; CANCER; MANAGEMENT; FERTILITY; LYMPHADENECTOMY; RISK;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Since patients with borderline ovarian tumors (BOTs) are relatively young with good survival rates, conservative surgery is prioritized as a therapeutic intervention. However, the high recurrence rate of this tumor remains an issue that demands further attention. In addition, it is unclear whether the increment of recurrent risk is attributed to conservative surgery or staging surgery. This study was designed to analyze the relapse-related factors of BOTs. Methods: This retrospective cohort study was comprised of 74 patients with BOTs who underwent surgery at the Obstetrics and Gynecology Hospital of Fudan University from September 2014 to September 2017. The recurrence-free survival (RFS) rate was calculated using the Kaplan-Meier method, while the risk factors of RFS were evaluated using Cox-regression analysis. Results: The 3-year RFS was 2.7% with a median follow-up duration of 45 months (range: 28-62). Kaplan-Meier analysis indicated that low tumor node metastasis (TNM) stage (P = 0.005), lymphadenectomy (P = 0.052) and fertility-preservation surgery (P = 0.059) were the factors that may lower recurrence. Meanwhile, Cox-regression showed that only low TNM stage was significantly associated with a better RFS (P = 0.005). Conclusions: With the removal of visible lesions by standard surgery, patients at TNM stage I had a better RFS. Fertility-preservation surgery did not increase the recurrence risk. For bilateral ovarian cyst however, it was unclear whether bilateral cystectomy can increase the recurrence risk. Therefore, further study is required.
引用
收藏
页码:5712 / 5718
页数:7
相关论文
共 50 条
  • [31] The impact of hysterectomy on oncological outcomes in postmenopausal patients with borderline ovarian tumors: A multicenter retrospective study
    Raimondo, Diego
    Raffone, Antonio
    Scambia, Giovanni
    Maletta, Manuela
    Lenzi, Jacopo
    Restaino, Stefano
    Mascilini, Floriana
    Trozzi, Rita
    Mauro, Jessica
    Travaglino, Antonio
    Driul, Lorenza
    Casadio, Paolo
    Mollo, Antonio
    Fagotti, Anna
    Vizzielli, Giuseppe
    Seracchioli, Renato
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [32] Safety of ovarian tissue transplantation in patients with borderline ovarian tumors
    Masciangelo, Rossella
    Bosisio, Chiara
    Donnez, Jacques
    Amorim, Christiani A.
    Dolmans, Marie-Madeleine
    HUMAN REPRODUCTION, 2018, 33 (02) : 212 - 219
  • [33] Risk factors that increase recurrence in borderline ovarian cancers
    Birge, Ozer
    Bakir, Mehmet Sait
    Karadag, Ceyda
    Dinc, Can
    Dogan, Selen
    Tuncer, Hasan Aykut
    Simsek, Tayup
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (07): : 8438 - 8449
  • [34] Is there a justification for hysterectomy in patients with borderline ovarian tumors?
    Ouldamer, L.
    Lacoste, C.
    Cormier, B.
    Arbion, F.
    Marret, H.
    Jallais, L.
    Fignon, A.
    Body, G.
    SURGICAL ONCOLOGY-OXFORD, 2016, 25 (01): : 1 - 5
  • [35] Conservative surgery for borderline ovarian tumors: A review
    Tinelli, R
    Tinelli, A
    Tinelli, FG
    Cicinelli, E
    Malvasi, A
    GYNECOLOGIC ONCOLOGY, 2006, 100 (01) : 185 - 191
  • [36] Conservative treatment of borderline ovarian tumors: the experience of one clinical center
    Olszewska, Hanna
    Abacjew-Chmylko, Anna
    Sawicki, Sambor
    Olszewski, Jaroslaw
    Wydra, Dariusz Grzegorz
    GINEKOLOGIA POLSKA, 2015, 86 (09) : 653 - 658
  • [37] Trends in incidence, treatment and survival of borderline ovarian tumors in the Netherlands: a nationwide analysis
    Schuurman, Melinda S.
    Timmermans, Maite
    van Gorp, Toon
    Van de Vijver, Koen K.
    Kruitwagen, Roy F. P. M.
    Lemmens, Valery E. P. P.
    van der Aa, Maaike A.
    ACTA ONCOLOGICA, 2019, 58 (07) : 983 - 989
  • [38] Pediatric Borderline Ovarian Tumors: A Retrospective Study of 15 Cases at a Single Institution
    Laboret, Bretton
    Scrushy, Marinda G.
    Pandya, Samir
    Murphy, Joseph T.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2025, 47 (02) : e77 - e82
  • [39] Risk factors for recurrence of borderline ovarian tumors in France: A multicenter retrospective study by the FRANCOGYN group
    Sangnier, E.
    Ouldamer, L.
    Bendifallah, S.
    Huchon, C.
    Collinet, P.
    Bricou, A.
    Mimoun, C.
    Lecointre, L.
    Graesslin, O.
    Raimond, E.
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2021, 50 (04)
  • [40] Elevated Preoperative CA125 or CA19-9 in Borderline Ovarian Tumors: Could It Be Suggestive of Advanced Stage or a Poor Prognosis?
    Song, Taejong
    Lee, Doo Haeng
    Jung, Yong Wook
    Yun, Bo Seong
    Seong, Seok Ju
    Choi, Chel Hun
    Lee, Jeong-Won
    Bae, Duk-Soo
    Kim, Byoung-Gie
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2018, 83 (01) : 45 - 51